DMAC - DiaMedica Therapeutics to Report Fourth Quarter 2019 Financials and Provide a Business Update March 24 2020
DiaMedica Therapeutics Inc. (Nasdaq: DMAC) today announced that its fourth quarter 2019 financial results will be released after the markets close on Monday, March 23rd. DiaMedica will host a live conference call on Tuesday, March 24th at 7:00 AM Central Time to discuss its business update and financial results.
Conference Call details:
Date: |
Tuesday, March 24, 2020 |
Time: |
7:00 AM CT / 8:00 AM ET |
Web access: |
https://event.on24.com/wcc/r/2220355/5404D6138C67936A6D82BAC008903CD8 |
Dial In: |
(844) 557-8483 (domestic) |
(825) 312-2381 (international) |
Conference ID: |
9270458 |
Interested parties may access the conference call by dialing in or listening to the simultaneous webcast. Listeners should log on to the website or dial in 15 minutes prior to the call. The webcast will remain available for play back on our website, under investor events and presentations, following the earnings call and for 12 months thereafter. A telephonic replay of the conference call will be available until March 31, 2020, by dialing (800) 585-8367 (US Toll Free), (416) 621-4642 (International), replay passcode 9270458.
About DiaMedica Therapeutics Inc.
DiaMedica Therapeutics Inc. is a clinical stage biopharmaceutical company focused on developing novel treatments for chronic kidney diseases and neurological disorders. DiaMedica’s shares are listed on The Nasdaq Capital Market under the trading symbol “DMAC.”
For more information, please visit www.diamedica.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20200317005072/en/
Scott Kellen
Chief Financial Officer
Phone: (763) 496-5118
skellen@diamedica.com